Lager Joanne Jenkins 4
4 · iTeos Therapeutics, Inc. · Filed Dec 10, 2021
Insider Transaction Report
Form 4
Lager Joanne Jenkins
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-12-10$4.30/sh+3,500$15,050→ 3,500 total - Exercise/Conversion
Stock Option (right to buy)
2021-12-10−3,500→ 203,438 totalExercise: $4.30Exp: 2025-06-11→ Common Stock (3,500 underlying) - Sale
Common Stock
2021-12-10$34.50/sh−3,500$120,750→ 0 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 23, 2021.
- [F2]One-fourth of the shares subject to the stock option vested on April 1, 2020. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis, subject to the reporting person's continuous service relationship with the Issuer through each applicable vesting date.